FDA Approved: NITYR — Supplemental Application (Cycle Pharmaceuticals Ltd.)

View source ↗

Summary

The FDA approved a supplemental application for NITYR (nitisinone) by Cycle Pharmaceuticals Ltd. This action updates the approved product and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Tyrosinemia Type

Drugs mentioned

• NITYR (Nitisinone)

Snippet

SUPPL AP for NITYR (NITISINONE)